LIFE FORWARD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

LIFE FORWARD Trademark

Serial Number: 79363829 • Registration: 7708778

LIFE FORWARD is a trademark filed by BOEHRINGER INGELHEIM INTERNATIONAL GMBH on November 19, 2022. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

BOEHRINGER INGELHEIM INTERNATIONAL GMBH (1,315 trademarks)

binger strasse 173
D-55216 INGELHEIM AM RHEIN , DE

Entity Type: 03

Trademark Details

Filing Date

November 19, 2022

Registration Date

March 4, 2025

Published for Opposition

July 30, 2024

Goods & Services

Educational services, namely, medical training and teaching, providing live and on-line education seminars in the medical and veterinary field, providing educational workshops in the medical and veterinary field; publishing of books, journals, and other publication on communication media in the medical, veterinary and pharmaceutical fields, namely, online electronic publishing of books and periodicals in the medical, veterinary and pharmaceutical fields; publication of texts, books, and journals in the medical, veterinary and pharmaceutical fields; Providing non-downloadable podcasts in the medical and veterinary field; publishing of journals, books and handbooks in the field of medicine; arranging and conducting of congresses and seminars in the medical, veterinary and pharmaceutical field; organization of exhibitions in the medical, veterinary and pharmaceutical fields for cultural or educational purposes

Recorded or downloadable computer software for use in database management in the healthcare field; Downloadable software in the nature of a mobile application for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information in the veterinary and medical field; downloadable mobile applications for creating, developing and providing personalized therapeutic recommendations associated with a defined set of symptoms for physicians and healthcare practitioners used to support clinical decision-making; downloadable mobile applications for use accessing healthcare information for the purpose of receiving personalized healthcare services and healthcare information; downloadable software as a medical device (SaMD) for treating mental health disorders and diseases of the central nervous system; downloadable Software as a Medical Device (SaMD) for use as a medical instrument for auscultation and for recording and transmission of body sounds made by internal organs for diagnostic purposes

Pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders, pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders, pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; stem-cells for medical purposes; biological tissue cultures for medical purposes; antibodies for medical purposes; vaccines; dietary supplements; dietetic preparations, namely dietetic foods and beverages adapted for medical use; veterinary preparations, namely, veterinary pharmaceutical preparations for the prevention and the treatment of metabolic diseases, veterinary pharmaceutical preparations for the prevention and the treatment of cardiovascular diseases, veterinary pharmaceutical preparations for the prevention and the treatment of neurological diseases and disorders, veterinary pharmaceutical preparations for the prevention and the treatment of musculoskeletal diseases and disorders, veterinary pharmaceutical preparations for the prevention and treatment of tendon and muscle damage and injuries, veterinary pharmaceutical preparations for the prevention and the treatment of hormonal diseases and disorders, veterinary pharmaceutical preparations against bacterial infections, namely, antibiotics, anti-infectives, veterinary pharmaceutical preparations for the prevention and the treatment of respiratory diseases, veterinary pharmaceutical preparations for the treatment of inflammatory diseases, veterinary pharmaceutical preparations for udder care, sedatives for animals; stem- cells for veterinary purposes; biological tissue cultures for veterinary purposes; veterinary vaccines; antiparasitics; dietary supplements for veterinary use; dietetic preparations for veterinary use, namely, dietetic foods and beverages adapted for veterinary use, dietetic pet foods adapted for veterinary purposes

Cosmetics for animals; animal grooming preparations, namely, non-medicated shampoos for animals, non-medicated pet shampoos

Chemicals for use in industry and science; biochemical preparations for use in industry and science, namely, biochemical reagents for scientific and research use, proteins for use in the manufacture of pharmaceuticals, proteins for scientific and medical research use; biological preparations for use in industry and science

Surgical, medical, dental apparatus and instruments, namely, medical imaging apparatus; medical apparatus for auscultation and for recording and transmission of body sounds made by internal organs for diagnostic purposes; veterinary apparatus and instruments, namely, surgical apparatus and instruments for veterinary use, Surgical apparatus and instruments for medical use; inhalation devices, namely, inhalers for medical purposes sold empty, medical apparatus for facilitating the inhalation of pharmaceutical preparations; injectors for medical purposes, namely, medical fluid injectors, syringes for injections, injection instruments without needles

Foodstuffs for animals

Medical, veterinary, pharmacological, biological and scientific research; conducting clinical trials for others; computer programming for others in the medical and veterinary field; design and development of computer software for others for use with medical technology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 15, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 15, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 4, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 4, 2025 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 4, 2025 NRCC
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 6, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 21, 2024 ETOF
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 11, 2024 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 21, 2024 OPNR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 7, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 6, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 3, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 24, 2023 REPR